Evidence map›Paper›PMID 33916067›Full record

ArticleJournal of clinical medicine2021

Risk of Reflux-Related Symptoms and Reflux Esophagitis after

Mitsushige Sugimoto, Masaki Murata, Eri Iwata, Naoyoshi Nagata, Takao Itoi, Takashi Kawai

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of clinical medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.3field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Improvement of dyspeptic symptoms afterJGH open : an open access journal of gastroenterology and hepatology · 2023
    Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Mitsushige SugimotoDepartment of Gastroenterological Endoscopy, Tokyo Medical University Hospital, Shinjuku, Tokyo 160-0023, Japan.ORCID 0000-0002-9194-7392
Masaki MurataDepartment of Gastroenterology, National Hospital Organization Kyoto Medical Center, Kyoto 612-8555, Japan.
Eri IwataDepartment of Gastroenterological Endoscopy, Tokyo Medical University Hospital, Shinjuku, Tokyo 160-0023, Japan.
Naoyoshi NagataDepartment of Gastroenterological Endoscopy, Tokyo Medical University Hospital, Shinjuku, Tokyo 160-0023, Japan.
Takao ItoiDepartment of Gastroenterology and Hepatology, Tokyo Medical University Hospital, Shinjuku, Tokyo 160-0023, Japan.
Takashi KawaiDepartment of Gastroenterological Endoscopy, Tokyo Medical University Hospital, Shinjuku, Tokyo 160-0023, Japan.
Tokyo Medical University Hospital · JPKyoto Medical Center · JPShiga University of Medical Science Hospital · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundsA meta-analysis of reports primarily from Western countries showed no association between

methodsAmong 148

resultsThe prevalence of reflux esophagitis in

conclusionsIn this

Indexed as

eradication therapygastric acidGERDHelicobacter pyloriquestionnaires

Identifiers

PMID33916067
PMCPMC8037794
OpenAlexW3141508619

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.